Search research articles
Contact Us
Filters
Showing results (121-130 of 124) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 124 results.
Clinical Pharmacology and Therapeutics
|
January 25, 2014
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update
K R Crews, A Gaedigk, H M Dunnenberger, et al.
Clinical Pharmacology and Therapeutics
|
March 25, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing
K A Birdwell, B Decker, J M Barbarino, et al.
Clinical Pharmacology and Therapeutics
|
May 15, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
J K Hicks, J R Bishop, K Sangkuhl, et al.
Clinical Pharmacology and Therapeutics
|
February 10, 2017
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future
A S Darwich, K Ogungbenro, A A Vinks, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 124) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 124 results.
Clinical Pharmacology and Therapeutics
|
January 25, 2014
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update
K R Crews, A Gaedigk, H M Dunnenberger, et al.
Clinical Pharmacology and Therapeutics
|
March 25, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing
K A Birdwell, B Decker, J M Barbarino, et al.
Clinical Pharmacology and Therapeutics
|
May 15, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
J K Hicks, J R Bishop, K Sangkuhl, et al.
Clinical Pharmacology and Therapeutics
|
February 10, 2017
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future
A S Darwich, K Ogungbenro, A A Vinks, et al.
Page
of 13